Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid Tumors

NCT02211755 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

NIH

Sponsor class

Conditions

Neoplasms
Myelodysplastic Syndromes
Lymphomas

Interventions

DRUG: Bortezomib plus Clofarabine

Sponsor

National Cancer Institute (NCI)